Publicacións nas que colabora con Ramón Colomer Bosch (12)

1989

  1. Circulating CA 15-3 antigen levels in non-mammary malignancies

    British Journal of Cancer, Vol. 59, Núm. 2, pp. 283-286

  2. Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases

    Breast Cancer Research and Treatment, Vol. 13, Núm. 2, pp. 123-133

  3. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease

    Cancer, Vol. 64, Núm. 8, pp. 1674-1681

1987

  1. Creatine kinase BB isoenzyme as a marker of CNS metastases in patients with small-cell lung cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

1986

  1. CA 15.3: early results of a new breast cancer marker.

    Anticancer research, Vol. 6, Núm. 4, pp. 683-684

  2. Circulating CA 15.3 levels in breast cancer. Our present experience.

    The International journal of biological markers, Vol. 1, Núm. 2, pp. 89-92

  3. Circulating antigen levels in ovarian cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

  4. Concentration of myelin basic protein in cerebrospinal fluid in prognosis of multiple sclerosis.

    Clinical chemistry

  5. El CA 15.3 sérico en mujeres afectas de patologías mamarias no tumorales. Primeros resultados.

    Medicina Clinica

  6. Myelin basic protein and creatine kinase BB isoenzyme as CSF markers of intracranial tumors and stroke

    Acta Neurologica Scandinavica, Vol. 73, Núm. 5, pp. 461-465

  7. Serum CA 15.3 levels in patients with general pathology and malignant diseases (excluding breast cancer).

    Bulletin du cancer, Vol. 73, Núm. 1, pp. 94-95

  8. Serum CA 15.3 levels in patients with non-tumoral diseases, and establishment of a threshold for tumoral activity. Results in 1219 patients.

    International Journal of Biological Markers